The activation of renin–angiotensin system is involved in hyperlipidemia mediated renal injuries in apolipoprotein E knockout mice

jie ni,k l ma,jing liu,x z ruan,bicheg liu

DOI: https://doi.org/10.1016/j.ijcard.2011.08.795

IF: 4.039

2011-01-01

International Journal of Cardiology

Abstract:Objective: It is well-known that hypertension and hyperlipidemia are independent risk factors in the progression of chronic kidney disease (CKD). The activation of renin–angiotensin system (RAS) is one of the main causes for the pathogenesis of hypertension in CKD. Whether there is a crosstalk between hyperlipidemia and RAS activation in accelerating the progression of CKD remains unknown. The present study was undertaken to investigate whether RAS activation plays a crucial role in hyperlipidemia mediated renal injuries in apolipoprotein E knockout mice (apoE−/− mice). Methods: Male apoE−/− mice were respectively fed with high fat diet (HF group, containing 40% fat and 0.15% cholesterol, n=8) and normal chow diet (control, n=8) for 8 weeks. The plasma levels of prorenin, rennin, and angiotensin II were checked by radiommunoassay. The protein expressions of angiotensinogen, angiotensin II, renin, angiotensin converting enzyme (ACE), angiotensin II type 1 receptor (AT1) and angiotensin II type 2 receptor (AT2) in kidneys of apoE−/− mice were checked by immunohistochemical staining and western blot. Results: The mice in HF group developed hyperlipidemia with significant extracellular matrix deposition in renal interstitium of kidneys compared to the controls. The plasma levels of renin and angiotensin II were not significant except that plasma prorenin level was significantly reduced in HF group compared to the controls. Immunohistochemical staining and western blot analysis showed that the protein expressions of angiotensinogen, angiotensin II, renin, ACE, AT1 and AT2 were significantly increased in the kidneys in HF group compared to the controls, which was significantly associated with the extracellular matrix deposition in kidneys of in HF group. Conclusion: Our pilot study demonstrated that the activation of intra-renal RAS was involved in hyperlipidemia mediated renal injuries, suggesting that it may have a crosstalk between hyperlipidemia and RAS activation in accelerating the progression of CKD.